Holen Sie sich die Stockscreener-App
18.05
0.39%
-0.07
Handel nachbörslich:
18.09
0.04
+0.22%
Schlusskurs vom Vortag:
$18.12
Offen:
$18.18
24-Stunden-Volumen:
9,809
Relative Volume:
0.48
Marktkapitalisierung:
$788.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-75.28M
KGV:
-9.0444
EPS:
-1.9957
Netto-Cashflow:
$-57.45M
1W Leistung:
-0.82%
1M Leistung:
-0.06%
6M Leistung:
-16.44%
1J Leistung:
+57.64%
1-Tages-Spanne:
$18.00
$18.20
1-Wochen-Bereich:
$17.89
$18.35
52-Wochen-Spanne:
$10.79
$23.08
Oculis Holding Ag Stock (OCS) Company Profile
Firmenname
Oculis Holding Ag
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie OCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCS
Oculis Holding Ag
|
18.05 | 917.08M | 0 | -75.28M | -57.45M | -1.9957 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-10-05 | Eingeleitet | Stifel | Buy |
| 2023-06-14 | Eingeleitet | BofA Securities | Buy |
| 2023-06-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-06-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-10 | Eingeleitet | Pareto | Buy |
| 2023-04-28 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Oculis Holding Ag Aktie (OCS) Neueste Nachrichten
Is Oculis Holding AG Equity Warrant’s ROE strong enough2025 Market WrapUp & Daily Oversold Stock Bounce Ideas - 선데이타임즈
What MACD signals say about Oculis Holding AGBuy Signal & Daily Chart Pattern Signals - Newser
Can technical indicators confirm Oculis Holding AG Equity Warrant’s reversal2025 Year in Review & Verified Stock Trade Ideas - Newser
Custom watchlist performance reports with Oculis Holding AG Equity WarrantJuly 2025 Opening Moves & Fast Entry and Exit Trade Plans - Newser
Tick level data insight on Oculis Holding AG Equity Warrant volatilityJuly 2025 Retail & Real-Time Chart Pattern Alerts - Newser
Will Oculis Holding AG outperform the market2025 Major Catalysts & Technical Entry and Exit Tips - Newser
Why Oculis Holding AG stock attracts strong analyst attentionMarket Volume Summary & High Conviction Buy Zone Picks - Newser
When is the best time to exit Oculis Holding AG2025 Market Overview & Free Real-Time Volume Trigger Notifications - Newser
Using flow based indicators on Oculis Holding AGEarnings Beat & Proven Capital Preservation Methods - Newser
Multi factor analysis applied to Oculis Holding AG Equity WarrantInsider Buying & Real-Time Volume Analysis Alerts - Newser
What’s next for Oculis Holding AG stock priceDollar Strength & Capital Efficiency Focused Ideas - Newser
What makes Oculis Holding AG stock price move sharplyEquity Performance Forecast Based on AI Models - Newser
Does Oculis Holding AG Equity Warrant fit your quant trading modelReal-Time Entry Forecast with Accuracy Metrics - Newser
Will Oculis Holding AG continue its uptrend2025 EndofYear Setup & Fast Momentum Entry Tips - Newser
Volume spikes in Oculis Holding AG stock – what they mean [Weekly Investment Summary]Expert-Curated Trade Recommendations - Newser
Should you wait for a breakout in Oculis Holding AG Equity WarrantShort Squeeze Opportunities with Indicators - Newser
Applying chart zones and confluence areas to Oculis Holding AGAI Trade Signal Forecast with Chart Logic - Newser
Oculis to present at H.C Wainwright Ophthalmology Virtual Conference. - AInvest
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - The Manila Times
Oculis to Participate in Upcoming H.C Wainwright 5th Annual Ophthalmology Virtual Conference - The Manila Times
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewswire Inc.
Using data models to predict Oculis Holding AG stock movementSwing Reversal Forecast Based on Patterns - Newser
Is Oculis Holding AG stock undervalued right nowCapital Expansion Stock Tips - newsyoung.net
Using economic indicators to assess Oculis Holding AG Equity Warrant potentialFree Trade Setups With Clear Risk Limits - Newser
Risk adjusted return profile for Oculis Holding AG Equity Warrant analyzedFree Weekly Return Pick Forecast Reports - Newser
Detecting support and resistance levels for Oculis Holding AGFundamental Forecast for Undervalued Stocks - Newser
Key metrics from Oculis Holding AG’s quarterly dataFree Triple Return Setup with Risk Control - Newser
Why Oculis Holding AG Equity Warrant is moving todayBuy and Hold Return Summary with Charts - Newser
how oculis holding ag equity warrant stock performs during market volatilityFree Consistent Gain Investment Strategies - Newser
Momentum divergence signals in Oculis Holding AG Equity Warrant chartFree Low Risk Buy Zone Opportunity Watch - Newser
What the charts say about Oculis Holding AG todayHistorical Market Behavior and Trend Summary - Newser
How to manage a losing position in Oculis Holding AGMomentum Stocks with Breakout Potential - Newser
What momentum shifts mean for Oculis Holding AG Equity WarrantEntry Optimization Tool with Screener Logic - Newser
Historical volatility pattern of Oculis Holding AG Equity Warrant visualizedFree Consistent Income Focused Trade List - Newser
Volume spikes in Oculis Holding AG stock – what they meanFree Technical Stock Breakout Predictions - Newser
Visual trend scoring systems applied to Oculis Holding AGLong Term Stock Growth Plan Suggestions - Newser
Is Oculis Holding AG stock trending bullishCapital Doubling Stock Strategy - thegnnews.com
Using Ichimoku Cloud for Oculis Holding AG technicalsPre-Market Stock Movement Summary and Review - Newser
Using Ichimoku Cloud for Oculis Holding AG Equity Warrant technicalsFree Stock Portfolio Allocation Guidance - Newser
Using flow based indicators on Oculis Holding AG Equity WarrantFree Weekly Chart Analysis With Entry Advice - Newser
Oculis Holding AG Reports Statutory Loss for 2024, Approves Capital Band for Future Equity-Based Compensation - AInvest
Oculis Shareholders Greenlight Massive $15.5M Executive Package and Strategic Capital Restructuring - Stock Titan
Should I hold or sell Oculis Holding AG stock in 2025Track top-performing stocks in real-time - Jammu Links News
Should I hold or sell Oculis Holding AG Equity Warrant stock in 2025Achieve breakthrough financial results - Jammu Links News
Is it the right time to buy Oculis Holding AG Equity Warrant stockBreakthrough stock performance - Jammu Links News
Finanzdaten der Oculis Holding Ag-Aktie (OCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):